Funding for a Cystic Fibrosis drug is being described as a miracle.
A provisional agreement's been made between Pharmac and Vertex to fund the drug Trikafta for those with the condition aged six and over.
The drug buying agency estimated it could give those people up to 27 more years of full health when compared with supportive care.
Cystic Fibrosis Chief Executive Lisa Burns told Tim Dower they know from other countries the drug's incredible life-changing effects.
“There is a different level of quality of life, there is the ability to put weight on, there’s the ability to work and attend school.”
LISTEN ABOVE

Mark Wilshire: Co-operative Bank CEO ahead of the Official Cash Rate announcement
03:26

Bevan McKenzie: Health NZ Chief Financial Officer on the inquiry into the Manage My Health cyber-attack
04:48

Steve Cullen: Criminal Lawyer on 2025 remand numbers dropping as prisoner numbers reach record highs
02:33